BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31886220)

  • 1. Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to
    Chen Y; Suo J; Du M; Chen L; Liu Y; Wang L; Liang Z
    Biomed Res Int; 2019; 2019():4931501. PubMed ID: 31886220
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
    Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
    Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
    Hand E; Davis H; Kim T; Duhon B
    J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
    Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F
    Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB; Nambiar V; Aravindakshan R; Al-Kasaby NM
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e66-e71. PubMed ID: 33777425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
    BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients.
    Demiraslan H; Sevim M; Pala Ç; Durmaz S; Berk V; Kaynar L; Metan G
    Int J Hematol; 2013 Mar; 97(3):414-20. PubMed ID: 23430671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
    Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
    Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and risk factors of infections caused by Stenotrophomonas maltophilia in a hospital in northwest China.
    Xun M; Zhang Y; Li BL; Wu M; Zong Y; Yin YM
    J Infect Dev Ctries; 2014 Aug; 8(8):1000-5. PubMed ID: 25116665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
    Hevia EC; Wooten L; Carr AL
    Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.
    Junco SJ; Bowman MC; Turner RB
    Int J Antimicrob Agents; 2021 Aug; 58(2):106367. PubMed ID: 34058337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
    Hotta G; Matsumura Y; Kato K; Nakano S; Yunoki T; Yamamoto M; Nagao M; Ito Y; Takakura S; Ichiyama S
    Kansenshogaku Zasshi; 2013 Sep; 87(5):596-602. PubMed ID: 24195169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
    Kim SH; Cha MK; Kang CI; Ko JH; Huh K; Cho SY; Chung DR; Peck KR
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):285-295. PubMed ID: 30421302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.
    Paez JI; Tengan FM; Barone AA; Levin AS; Costa SF
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):901-6. PubMed ID: 18483755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.